KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Biogen (BIIB) Short term Debt (2016 - 2025)

Biogen (BIIB) has 12 years of Short term Debt data on record, last reported at $150.0 million in Q2 2025.

For Q2 2025, Short term Debt changed N/A year-over-year to $150.0 million; the TTM value through Jun 2025 reached $150.0 million, changed N/A, while the annual FY2023 figure was $150.0 million, N/A changed from the prior year.
Short term Debt reached $150.0 million in Q2 2025 per BIIB's latest filing, roughly flat from $150.0 million in the prior quarter.
Across five years, Short term Debt topped out at $999.1 million in Q4 2021 and bottomed at $150.0 million in Q4 2023.
Average Short term Debt over 3 years is $433.0 million, with a median of $150.0 million recorded in 2023.